Patents Assigned to Orthro-McNeil Pharmaceutical, Inc.
  • Cyclodextrin cladribine formulations
    Patent number: 6194395
    Abstract: There is provided by the present invention liquid injectable and oral solid pharmaceutical dosage forms containing a mixture of cladribine (2-chloro-2′-deoxyadenosine; 2-CdA) and cyclodextrin.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: February 27, 2001
    Assignee: Orthro-McNeil Pharmaceutical, Inc.
    Inventors: Thomas W. Schultz, Rainer Naeff